Precision Medicine and Value-Based Payment in Oncology

A session at the Association of Community Cancer Centers (ACCC) 48^th Annual Meeting and Cancer Center Business Summit brought together industry experts to discuss innovations and obstacles in precision medicine and value-based payment in oncology.

The panel participants included Alexis Finkelberg Bortniker, JD, Partner, Foley & Lardner; Ira Klein, MD, MBA, FACP, Vice President, Medical Affairs & Payer Relations, Tempus Labs; Deirdre Saulet, PhD, Expert Partner, Advisory Board Company; James Hamrick, MD, MPH, Vice President, Clinical Oncology, Flatiron Health; and Nate Walcker, MBA, Chief Executive Officer, Florida Cancer Specialists & Research Institute.

“Value may be one of the most overused words in health care,” said Dr Saulet, explaining that the definition of value varies significantly. When defining...